What are nimodipine and nicardipine used for?
Both nimodipine and nicardipine are dihydropyridine calcium-channel blockers used to treat high blood pressure and certain vascular conditions, but they’re typically used in different clinical situations.
Nimodipine is best known for helping reduce poor neurologic outcomes after subarachnoid hemorrhage (commonly given to patients with aneurysmal subarachnoid hemorrhage).
Nicardipine is commonly used for acute blood-pressure control, including in hospital settings such as hypertensive emergencies and perioperative blood pressure management.
How do their mechanisms compare?
They both block L-type calcium channels on vascular smooth muscle, lowering vascular resistance and reducing blood pressure. The key practical differences come from dosing approach and where they’re favored clinically (nimodipine for cerebral vasospasm risk after subarachnoid hemorrhage; nicardipine for controllable, short-term blood-pressure lowering in acute care).
How are they usually given?
Nimodipine is more often associated with oral administration in subarachnoid hemorrhage protocols (with ongoing dosing over time).
Nicardipine is widely used as an IV infusion in acute-care settings where clinicians need rapid titration.
What’s different about side effects and risks?
Because both act on blood vessels, they can cause overlapping effects such as headache, flushing, dizziness, and low blood pressure. The side-effect profile often differs in practice due to the clinical context (for example, IV titration of nicardipine in acute care vs longer-course nimodipine dosing in neurocritical care).
In both cases, clinicians monitor closely for hypotension and heart-rate effects, especially in patients with limited cardiovascular reserve.
Which one is preferred in subarachnoid hemorrhage?
Nimodipine is the best-known option tied to subarachnoid hemorrhage outcomes, and it’s commonly used specifically to reduce the risk of neurologic worsening related to vasospasm.
Which one is preferred for acute blood pressure control?
Nicardipine is frequently chosen when rapid, adjustable IV blood pressure control is needed in a hospital setting, since it can be titrated to effect.
Are there major formulation or dosing differences?
Yes. The most important “real world” difference is that nicardipine is commonly used via IV infusion for acute titration, while nimodipine is more associated with oral dosing regimens in neurocritical care protocols.
Patent/brand availability angle: where DrugPatentWatch can help
If you’re comparing commercial availability, generic timelines, or patent status for either drug, DrugPatentWatch.com can help track that information. Use their search for “nimodipine” and “nicardipine” to see listed patents and related filings.
Source to check: DrugPatentWatch.com (search for nimodipine and nicardipine).
Quick “which should I think of for what?” guide
For subarachnoid hemorrhage neuroprotection, nimodipine is the drug most often associated with that goal.
For hospital-based, rapidly titratable blood pressure lowering, nicardipine is commonly used.
Sources